Let's be precise about what happened, because the headline flattens it. The Warriors didn't sign Kristaps Porzingis this week. They already had him — they gave up Jonathan Kuminga and Buddy Hield to pry him out of Atlanta at the February 5 deadline. What they did this week was decide to keep the thing they bought. Two years, $40 million, with a player option on the second. That's the whole story, and the whole story is a gamble dressed up as a no-brainer.

Start with the basketball, because the basketball is the easy part. Porzingis is 7'3" and shoots 36% from three, and when he was upright last season he was exactly what this roster has been starving for. In 15 games after the trade he put up 16.1 points, 5.3 boards and better than a block a night in 23.7 minutes — and the defensive number that matters more is this: he led the NBA in rim-protection field-goal percentage against expectation, holding shooters at the basket roughly fifteen points below where they should've finished. That is the rare big who lets you trap Curry on the perimeter without surrendering the paint. Trap Steph, Porzingis pops free for three. Switch, and he shoots over the little guy. Kerr called him "a really easy guy to play with," which from Kerr is practically a sonnet.

Now the hard part. Porzingis played 32 games all of last season. Thirty-two. He's managing POTS — postural orthostatic tachycardia syndrome, a condition where his heart rate spikes toward 130 just from standing up — on top of left Achilles tendinitis that flared in January. You don't game-plan around that. You hope around it. When a reporter asked if he'd get healthy, the man's answer was, "I don't know, but I'm confident that I will." That's an honest sentence, and it should make you nervous and a little moved at the same time.

Here's why I think Mike Dunleavy got this right anyway. He could have handed Porzingis the three-year, $116 million extension the big was technically eligible for. He didn't. He went two years and $40M with an out, which is the front-office version of a half-unit when your read is good but the injury risk is real — you size down, you don't fold. If the heart and the heel cooperate, Golden State is paying $20M a year for a top-shelf stretch-five on a contender. If they don't, the deal is short enough to step over. The downside is bounded. That's the whole point.

The complication nobody's saying out loud: this roster is held together with tape. Jimmy Butler tore his ACL on January 19 and his availability for 2026-27 is a genuine question mark. Draymond declined his $27.7M option and is, as of today, a free agent. Al Horford — 39 years old, 45 games last year — re-upped for two years and $14M as the insurance policy. The Warriors finished 37-45, and the autopsy pointed straight at the frontcourt. Porzingis was the clearest upgrade available to a team that, for the first time since 2019-20, is operating under the luxury tax. So they made the bet they could afford on the player who moves the needle most.

No line to put on the board here — it's June 30, there's no game to price, and any Warriors win-total or title number right now is guessing through Draymond's free agency and Butler's knee. Line not pulled — analysis only. So no units on this one.

But if I were grading the decision the way I grade a ticket: the structure is sharp, the fit is real, and the risk is a heartbeat the medical staff can't promise. I'd have made the same call. I'd also have lit a candle on the way out of the building.